<DOC>
	<DOCNO>NCT01229982</DOCNO>
	<brief_summary>The purpose study test latanoprost punctal plug reduce eye pressure subject ocular hypertension open-angle glaucoma .</brief_summary>
	<brief_title>A Study Evaluating Latanoprost Punctal Plug Delivery System ( L-PPDS ) Subjects With Ocular Hypertension Open-Angle Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Diagnosed bilateral OH OAG topical prostaglandin monotherapy bilaterally standard care treatment OH OAG . Adequate IOP control topical prostaglandin monotherapy past 1 month . Functionally significant vision loss , progressive field loss within last year . Contact lens wear time treatment period . Keratoconjunctivitis sicca require chronic topical artificial tear , lubricant , and/or Restasis® . Active lid disease ( i.e. , moderate severe blepharitis , meibomianitis ) require medical treatment . Subjects ≥0.9 vertical cup completely notch optic nerve head rim . Currently chronic ocular topical medication Currently ophthalmic systemic steroid therapy . Laser surgery glaucoma within last 3 month 6 month incisional surgery . History macular edema History chronic/recurrent inflammatory eye disease . History nonresponse topical prostaglandin therapy . Subjects epiphora .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>